Перевести на Переведено сервисом «Яндекс.Перевод»

Inovio Pharmaceuticals

Страна
USA
Краткое название
Inovio Pharmaceuticals
Штаб квартира
Building 18 Suite 400
Члены правления

J. Joseph Kim, Ph.D.,
President, Chief Executive Officer, Director
Peter Kies,
Chief Financial Officer
Niranjan Y. Sardesai, Ph.D.,
Chief Operating Officer
Mark L. Bagarazzi, M.D.,
Chief Medical Officer
Stephen Kemmerrer,
Vice President, Engineering Operations
Thomas Kim, Esq.,
Vice President, Legal and Corporate Secretary

Разделы медицины
Онкология, Инфекционные болезни
Стадия проекта
Производство
Заболевания
ВИЧ, Грипп, Рак женских половых органов
Тикер
INO
Текущие владельцы

Avtar Dhillon, M.D.,
Chairman of the Board, Inovio Pharmaceuticals
Simon X. Benito,
Former Senior Vice President, Vaccine Division, Merck
Angel Cabrera, Ph.D.,
President, George Mason University
Morton Collins, Ph.D.,
General Partner, Battelle Ventures
J. Joseph Kim, Ph.D.,
President & Chief Executive Officer, Inovio Pharmaceuticals
Adel Mahmoud, Ph.D.,
Former President, Merck Vaccines and Chief Medical Advisor, Vaccines & Infectious Diseases, Merck
Professor, Dept. of Molecular Biology, Princeton University

Объем фонда
631.5600
Технологии
Вакцины, Клеточные технологии, Фармацевтика, Химия